Media

May 13, 2022 | In the News
BioSpace Movers & Shakers: Singular Genomics, Marengo, Ventyx, Caribou and More
BIOSPACE: Building stronger companies requires the right leadership. This week, life sciences companies from across the globe pinpoint the Movers & Shakers who will best benefit their company.
May 5, 2022 | Publication
Lymph node-targeted vaccine boosting of TCR-T cell therapy enhances anti-tumor function and eradicates solid tumors
BioRxIV, Drakes, et. al.
April 29, 2022 | Publication
Lymph-Node Targeted Boosting with Cognate Amphiphile-Peptide Vaccines Enhances TCR-T Cell Therapy to Eradicate Solid Tumors
Presentation — Keystone Emerging Cellular Therapies Conference 2022, Dylan Drakes, PhD
March 29, 2022 | Publication
A Lymph-node Targeted Protein Subunit Vaccine Induces Potent and Cross-reactive Cellular and Humoral Immunity to COVID-19 in Mice and Non-Human Primates
Presentation — Vaccine Summit Boston 2022, Pete DeMuth, PhD
March 23, 2022 | Publication
Lymph-Node Targeted TLR9 Agonists Enable Potent Cellular Immune Responses Against Cancer & Infectious Disease
Presentation — STING & TLR — Targeting Therapies Summit 2022, Pete DeMuth, PhD
March 11, 2022 | In the News
What’s the key to being a leader in the industry?
PHARMA'S ALMANAC: Progress in Therapeutics
March 11, 2022 | In the News
What important company milestone do you anticipate reaching in 2022?
PHARMA'S ALMANAC: 2022 Milestones
March 1, 2022 | In the News
Scrip Asks…What Does 2022 Hold For Biopharma? Part 4: Therapeutic Area Advances
SCRIP: High Hopes In COVID-19, Cancer, CNS, Immunology And Rare Disease
January 11, 2022 | In the News
CEO to CEO: Tips for First-time Founders
BIOSPACE: We picked the brains of 10 biotech CEOs and founders to solicit their advice for first-time founders. Here’s what they told us:
November 12, 2021 | Publication
Amphiphile-Peptide Boosting with FMC63-binding Surrogate Peptide Mimotopes Induces Activation and Potent Effector Function in CAR-T Cells Targeting CD19
Scientific Poster